首页> 外文期刊>ERJ Open Research >The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis
【24h】

The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis

机译:FACED和E-FACED评分的年度预后能力可预测支气管扩张患者的死亡率

获取原文
获取外文期刊封面目录资料

摘要

Bronchiectasis is a disease defined by a permanent and usually progressive bronchial dilation associated with multiple exacerbations and decreased health-related quality of life [1–3]. Improvement in the current knowledge of this condition's pathophysiology has clearly highlighted its complex and heterogeneous profile, whose severity or prognosis cannot be defined using a single variable [4]. Accordingly, multidimensional scores including demographical, clinical, microbiological and radiological data have recently been developed and validated as useful tools to better evaluate the disease's severity and prognosis: FACED (forced expiratory volume in 1?s (FEV1), age, chronic colonisation by Pseudomonas aeruginosa , radiological extension and dyspnoea), E-FACED (FACED plus exacerbations) and the bronchiectasis severity index (BSI) [5–8].Both FACED and E-FACED scores have shown good short-term prognostic value for predicting mortality in bronchiectasis http://ow.ly/albl30i11bv
机译:支气管扩张是一种由永久性,通常为进行性支气管扩张引起的疾病,伴有多发性加重和与健康有关的生活质量下降[1-3]。目前对这种疾病的病理生理学认识的提高清楚地表明了其复杂而异质的特征,其严重性或预后无法用单个变量定义[4]。因此,最近开发并验证了包括人口统计学,临床,微生物学和放射学数据在内的多维评分,可以作为更好地评估疾病严重程度和预后的有用工具:FACED(强迫呼气量1?s(FEV1),年龄,假单胞菌的慢性定植)铜绿假单胞菌,放射学扩展和呼吸困难),E-FACED(FACED加急性加重)和支气管扩张严重性指数(BSI)[5-8]。FACED和E-FACED评分均显示出良好的短期预后价值,可预测支气管扩张的死亡率

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号